KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EBT (2017 - 2025)

Guardant Health (GH) has disclosed EBT for 9 consecutive years, with -$130.2 million as the latest value for Q4 2025.

  • Quarterly EBT fell 18.07% to -$130.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$417.5 million through Dec 2025, up 4.03% year-over-year, with the annual reading at -$417.5 million for FY2025, 4.03% up from the prior year.
  • EBT hit -$130.2 million in Q4 2025 for Guardant Health, down from -$92.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$72.3 million in Q2 2023 to a low of -$229.0 million in Q2 2022.
  • Historically, EBT has averaged -$118.5 million across 5 years, with a median of -$107.6 million in 2021.
  • Biggest five-year swings in EBT: plummeted 237.1% in 2021 and later soared 68.44% in 2023.
  • Year by year, EBT stood at -$72.3 million in 2021, then crashed by 92.71% to -$139.3 million in 2022, then plummeted by 34.63% to -$187.6 million in 2023, then soared by 41.21% to -$110.3 million in 2024, then dropped by 18.07% to -$130.2 million in 2025.
  • Business Quant data shows EBT for GH at -$130.2 million in Q4 2025, -$92.6 million in Q3 2025, and -$99.9 million in Q2 2025.